Skip to main content

NED Biosystems was founded to
allow patients to achieve and sustain 
No Evidence of Disease

Reimagining Treatments for Complex Disease

NED Biosystems™, a Public Benefit Corporation, was founded to develop safe, efficacious, and comprehensive “systems” treatments for complex disease, beginning with the development of the patented NED-170 for treatment of cancer. A systems-based approach to treat disease comprehensively targets the behavior of the entire biological system instead of a single component.

NED-170 takes a systems approach that combines repurposed, oral agents well-documented in humans to affect critical cancer driving processes at doses that lack customary toxicity and side effects.

NED has deployed its systems methodology to develop NED-260 to be a universal antiviral treatment for a broad range of existing infectious diseases and those not yet known.

NED’s treatment platform strives to lessen the impact some of the deadliest diseases faced by patients today.

Our Values

Our values are driven by the belief that everyone deserves access to safe, oral, effective therapies regardless of age, race, economic status, or geographic location.

Close Menu